Is 2159.HK overvalued or undervalued?

2159.HK currently has a P/E ratio of 10.19. Relative to the sector average of 26.80, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

Can I buy fractional shares of 2159.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 2159.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 2159.HK to protect their purchasing power. Because 2159.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 2159.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 2159.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 2159.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks2159.HK

Mediwelcome Healthcare Management & Technology Inc.

Q: How can I buy Mediwelcome Healthcare Management & Technology Inc. stock?

Mediwelcome Healthcare Management & Technology Inc. trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

HK$1.66-HK$0.03-1.49%

HKSE / HKD

Market cap

HK$449M

P/E

10.2

EPS (TTM)

HK$0.02

Dividend yield

0.00%

Beta

-0.25

1Y return

+31.75%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$111M2021

$47M2022

$47M2023

$44M2024

$67M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.50Low
Current ratio0.71
Cash ratio0.56
Net margin5.9%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

2159.HK10.2
Healthcare sector median26.8
S&P 50022.0

Trades about 62% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.01
Price to book2.47
EPS (TTM)HK$0.02
Payout ratio0%
FCF yield1.03%

Range & risk

HK$1.09HK$2.27

Trading in the middle of its 52-week band

Beta-0.25

Profile

What Mediwelcome Healthcare Management & Technology Inc. actually does

As an investment holding entity, Mediwelcome Healthcare Management & Technology Inc. delivers comprehensive marketing solutions for the healthcare sector within the People's Republic of China. Its service portfolio encompasses medical conference organization, patient education and screening programs, along with strategic marketing and advisory support. Additionally, the company provides Contract Research Organization (CRO) services, specifically focusing on patient recruitment and clinical data gathering. Furthermore, Mediwelcome manages a mobile application that facilitates internet hospital functionalities, including virtual follow-up consultations for physicians' current patients and electronic prescription services. Its diverse client base includes pharmaceutical firms, medical associations, and various foundations. Established in 2000, Mediwelcome Healthcare Management & Technology Inc. maintains its headquarters in Beijing, China.

CEO

Liang Wang

Employees

150

Headquarters

Beijing, BE

Founded

2021-01-19

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 2159.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

2159.HK has a beta of -0.25, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Mediwelcome Healthcare Management & Technology Inc.